Surfactant replacement therapy for severe acute respiratory distress syndrome in a child;Interet du surfactant exogene dans la traitement du syndrome de detresse respiratoire aigue de l'enfant

Archives de Pediatrie

Volumn 3, Issue 9, 1996, Pages 891-895

  Fraisse, A ^a   Paul, O ^a   Silicani, M A ^a   Viard, L ^a   Camboulives, J ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

child; pulmonary surfactants; respiratory distress syndrome; respiratory distress syndrome, adult; respiratory syncytial viruses

Indexed keywords

LUNG SURFACTANT EXTRACT; METHYLPREDNISOLONE; NITRIC OXIDE; BIOLOGICAL PRODUCT; LUNG SURFACTANT; PHOSPHOLIPID; PORACTANT;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CHILD; CLINICAL FEATURE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRATRACHEAL DRUG ADMINISTRATION; LUNG FUNCTION; SURVIVAL; VIRUS INFECTION; ACUTE DISEASE; FEMALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; PATHOPHYSIOLOGY; PRESCHOOL CHILD; TRACHEA;

ACUTE DISEASE; BIOLOGICAL PRODUCTS; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT, NEWBORN; NITRIC OXIDE; PHOSPHOLIPIDS; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; TRACHEA;

EID: 0030228064     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0929-693X(96)87581-6     Document Type: Article

References (18)

1. 1 Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967;ii:319-23
2. 2 Fowler AA, Hammam RF, Zerbe GO, Benson KN, Hyers TM. Adult respiratory distress syndrome. Prognosis after onset. Am Rev Respir Dis 1985;132:472-8
3. 3 Royall JA, Levin DL. Adult respiratory distress syndrome in pediatric patients. I. Clinical aspects, pathophysiology, pathology and mechanisms of lung injury. J Pediatr 1988;112:169-80
4. 4 Rayet I, Blanc PL, Holzapfel L, Robert D. Le syndrome de détresse respiratoire de «type adulte» en pédiatrie. À propos de 20 observations. Arch Fr Pédiatr 1986;43:29-34
5. 5 Pfenninger J, Tschaeppeler H, Wagner BP, Weber J, Zimmerman A. The paradox of Adult Respiratory Distress Syndrome in Neonates. Pediatr Pulmonol 1991;10:18-24
6. 6 DeBruin W, Notterman DA, Magid M, Godwin T, Johnston S. Acute hypoxemic respiratory failure in infants and children: Clinical and pathologic characteristics. Crit Care Med 1992;20:1223-34
7. 7 Lain DC, DiBenedetto R, Morris SL, Van Nguyen A, Saulters R, Causey D. Pressure control inverse ratio ventilation as a method to reduce peak inspiratory pressure and provide adequate ventilation and oxygenation. Chest 1989;95: 1081-8
8. 8 Hickling KG, Walsh J, Henderson S, Jackson R. Low mortality rate in adult respiratory distress syndrome using low-volume, pressure-limited ventilation with permissive hypercapnia. A prospective study. Crit Care Med 1994;22: 1568-78
9. 9 Morton A, Dalton H, Kochanek P, Janosky J, Thompson A. Extracorporeal membrane oxygenation for pediatric respiratory failure: Five-year experience at the university of Pittsburg. Crit Care Med 1994;22:1659-67
10. 10 Rossaint R, Schmidt-Ruhnke A, Steudel W, Pappert D, Kaiser U, Falke K. Retrospective analysis of survival in patients with severe acute respiratory distress syndrome treated with and without Nitric Oxyde inhalation. In: Critical Care Medicine, eds. Society of Critical Care Medicine's 24th Educational and Scientific Symposium. San Francisco: Crit Care Med, 1995;23(suppl 1):A112
11. 11 Arnold JH, Hanson JH, Toro-Fwiguero LO, Gutierrez J, Berens RJ, Anglin DL. Prospective, randomized comparison of high-frequency oscillatory ventilation and conventional mechanical ventilation in pediatric respiratory failure. Crit Care Med 1994;22:1530-39
12. 12 Zupan V, Lacaze-Masmonteil T. Le surfactant pulmonaire:de la physiopathologie à la thérapeutique. Med Sci 1993;9:277-87
13. 13 Pramanik AK, Holtzman RB, Merritt TA. Surfactant replacement therapy for pulmonary diseases. Pediatr Clin North Am 1993;40:913-36
14. 14 Pison U, Obertacke U, Brand M et al. Altered pulmonary surfactant in uncomplicated and septicemia complicated courses of acute respiratory failure. J Trauma 1990;30: 19-26
15. 15 Cummings JJ, Holm BA, Hudak ML, Hudak BB, Ferguson WH, Egan EA. A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs. Am Rev Respir Dis 1992;145:999-1004
16. 16 Spragg RG, Gilliard N, Richman P et al. Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome. Chest 1994; 105:195-202
17. 17 Heikinheimo M, Hynynen M, Rautiainen P, Andersson S, Hallman M, Kukkonen S. Successful treatment of ARDS with two doses of synthetic surfactant. Chest 1994; 105: 1263-4
18. 18 Weg JG, Balk RA, Tharratt RS et al. Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome. JAMA 1994;272:1433-8